Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,610,502
+$5,989,108 QoQ
Shares Held
3,442,430
-49.2% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#15
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Mar 31, 2026CallValue
$1,797,000
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,658,702,438 across 15 Drug Manufacturers - General names. OGN ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,516,475 | $381,605,769 | |
| 2 | LLY |
ELI LILLY & Co
|
182,678 | $219,109,491 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,458,924 | $184,320,458 | |
| 4 | SNY |
Sanofi
|
3,727,890 | $159,031,787 | |
| 5 | JNJ |
Johnson & Johnson
|
594,091 | $150,881,291 | |
| 6 | NVS |
Novartis AG
|
758,029 | $118,798,304 | |
| 7 | AZN |
Astrazeneca PLC
|
581,913 | $110,342,343 | |
| 8 | NVO |
Novo Nordisk A S
|
2,035,939 | $97,602,915 |
All Filings in OGN
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,610,502 | 3,442,430 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,797,000 | 300,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $40,621,394 | 6,781,535 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,304,997 | 460,948 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $693,132 | 64,900 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $48,354,073 | 4,527,535 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,995,720 | 9,090,467 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $1,930,192 | 199,400 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $2,543,904 | 262,800 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $14,558,593 | 977,743 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $1,489,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $282,226 | 18,916 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $6,714,000 | 450,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $1,752,939 | 91,633 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,267,960 | 302,800 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $1,362,370 | 65,815 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,981,322 | 158,581 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $1,020,840 | 54,300 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $16,287,563 | 1,129,512 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $1,442,000 | 100,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $868,000 | 50,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $19,952,334 | 1,149,328 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,860,619 | 858,271 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $3,131,905 | 150,500 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $2,868,334 | 121,953 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,275,400 | 1,298,797 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,307,109 | 696,885 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $843,750 | 25,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $17,570,523 | 503,021 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,304,356 | 42,836 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,273,265 | 69,328 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,673,341 | 418,815 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||